For decades, eggs were vilified first for cholesterol concerns, then for their association with meat-heavy diets. Yet a growing body of research has quietly been pointing in a different direction, particularly regarding brain health. Now, the most rigorous study to date on the topic has delivered a striking result: regular egg consumption was associated with a significantly lower risk of developing Alzheimer’s disease over 15 years of follow-up, and eating no eggs at all was linked to a measurably higher risk.
The study, published in The Journal of Nutrition in 2026, drew on data from the Adventist Health Study-2 and Medicare records, tracking nearly 40,000 Americans for an average of 15 years. It is, by a considerable margin, the largest and longest prospective investigation of egg intake and incident Alzheimer’s disease conducted to date.
The Study: Scale, Design, and What Made It Different
The research drew from the Adventist Health Study-2 (AHS-2), a long-running cohort of over 96,000 members of the Seventh-day Adventist Church enrolled across all 50 US states between 2002 and 2007. For this analysis, researchers focused on 39,498 participants aged 65 and older, whose dietary habits were assessed at baseline using a validated, detailed food frequency questionnaire covering more than 200 food items.
What distinguished this study from most previous work on diet and dementia was its use of an outcome measure. Rather than relying on self-reported cognitive decline or short-term assessments, the researchers linked participant data with Medicare claims records, the national health insurance program for Americans over 65, to identify clinically diagnosed Alzheimer’s disease using standardized ICD-10 diagnostic codes. This is a substantially more reliable measure than subjective cognitive tests or questionnaire-based memory complaints.
Over an average follow-up of 15.3 years, encompassing more than 600,000 person-years of observation, 2,858 participants developed Alzheimer’s disease, a cumulative incidence of 4%. Researchers then analyzed whether baseline egg consumption predicted who would and who would not develop the disease.
The Numbers: A Clear, Dose-Related Pattern
Egg intake was divided into five categories: never or rarely, one to three times per month, once per week, two to four times per week, and five or more times per week. The reference group, those who never or rarely ate eggs, consistently had the highest Alzheimer’s risk across all adjusted statistical models.
After accounting for demographics, lifestyle factors, physical activity, sleep, smoking, alcohol use, intake of other food groups, and pre-existing medical conditions, the hazard ratios compared to the never/rarely group were:
- 17% lower risk for eating eggs one to three times per month
- 17% lower risk for eating eggs once per week
- 20% lower risk for eating eggs two to four times per week
- 27% lower risk for eating eggs five or more times per week
The pattern was consistent and statistically significant across all three progressively adjusted models, and it remained unchanged when vegans were excluded from the analysis a sensitivity check designed to ensure that the non-egg-eating group was not being skewed by the health characteristics of vegans, who can differ systematically from the general population in multiple lifestyle factors.
A particularly striking finding emerged from the restricted cubic spline analysis, a statistical technique that maps risk across the full continuous range of egg intake. Among people eating zero eggs per day, the adjusted risk of Alzheimer’s disease was 22% higher than among those eating approximately 10 grams per day (roughly equivalent to one egg per week). The risk declined with increasing egg intake, though the additional reductions beyond moderate intake were not statistically significant.
Why Eggs? The Biological Case for Brain Protection
The association found in the study is not biologically arbitrary. Eggs are unusually concentrated sources of several nutrients that have independently been linked to brain health and protection against neurodegeneration.
Choline is perhaps the most discussed. It is a precursor to acetylcholine, a neurotransmitter critically involved in memory formation and learning, and to phosphatidylcholine, a key structural component of cell membranes. Research has documented that choline deficiency is measurable in the brains of people with Alzheimer’s disease. A single large egg contains roughly 147 mg of choline, making eggs one of the richest dietary sources available.
DHA (docosahexaenoic acid), an omega-3 fatty acid found in egg yolks, plays an essential role in synaptic plasticity, the brain’s ability to strengthen connections between neurons in response to activity, as well as in neurogenesis and the structural integrity of neuronal membranes. Deficiencies in DHA have also been documented in Alzheimer’s brain tissue.
Lutein and zeaxanthin, carotenoids concentrated in egg yolks, accumulate preferentially in brain tissue and have been associated with better cognitive performance and reduced oxidative stress in the aging brain.
Tryptophan, another abundant nutrient in eggs, serves as a precursor to serotonin, melatonin, and other neuroactive compounds involved in mood regulation, cognitive function, and sleep quality. Emerging research has highlighted a role for tryptophan-derived peptides from eggs in improving attention and reducing stress reactivity in older adults.
Vitamin B12 adds another layer. One egg provides roughly 25% of the recommended daily allowance of B12, a nutrient critical for one-carbon metabolism, whose deficiency is associated with elevated homocysteine levels, a recognized risk factor for Alzheimer’s disease. B12 deficiency is particularly common in vegetarian diets that exclude all animal products, a relevant consideration given the study population’s dietary composition.
Together, these nutrients may act synergistically rather than independently, supporting what the researchers describe as “cognitive resilience” the brain’s capacity to withstand or recover from the cellular stresses associated with aging and neurodegeneration.
What About Cholesterol?
A reasonable question is whether the cardiovascular risk historically associated with egg consumption might complicate this picture, particularly given that heart disease and Alzheimer’s disease share several common risk factors. The researchers addressed this directly: recent meta-analyses and systematic reviews have found that moderate egg consumption does not adversely affect cardiovascular or metabolic health in most people, especially when eggs are consumed as part of a varied diet. In this study, the analysis was adjusted for cardiovascular disease, hypertension, hyperlipidemia, and other comorbidities — meaning the Alzheimer’s association emerged independently of these conditions.
Who Was Studied and Why It Matters
The AHS-2 cohort is not a random cross-section of the American public. It is a group of Seventh-day Adventists, a population known for health-conscious lifestyles: roughly 80% had never smoked, very few consumed alcohol, and the cohort spanned the full spectrum of dietary patterns, from vegan to omnivore. This diversity in dietary practices, including a substantial proportion who consumed no eggs, is precisely what made this cohort well-suited to study the effect of egg intake in isolation from other dietary confounders.
Notably, the researchers point out that egg consumption in this population was lower than in the general US population. If anything, this would tend to underestimate the observed protective association, suggesting the real-world effect in a population with higher baseline egg consumption might be at least as large.
Important Limitations to Keep in Mind
This study cannot establish causation; it is observational, and even with extensive statistical adjustment, residual confounding from unmeasured variables cannot be entirely excluded. Diet was assessed only at baseline, so any dietary changes during the 15-year follow-up are not captured. The Alzheimer’s diagnoses were drawn from Medicare records, which may miss milder or less clinically obvious cases. And the study population, predominantly White and Black Seventh-day Adventist Americans, may not fully represent more diverse global populations.
The researchers also acknowledge a structural challenge: because death is a competing risk in Alzheimer’s studies of older adults, the hazard ratios reflect the rate of Alzheimer’s diagnosis among those alive and event-free, rather than absolute population-level risk differences.
These are genuine limitations, and the authors are transparent about them. What they do not do is invalidate the core finding, which is consistent with multiple independent lines of evidence from Finland, Spain, China, and the United States.
The Bigger Picture: Diet as a Tool Against Dementia
With no curative treatment for Alzheimer’s disease and its pathological changes beginning up to 20 years before symptoms appear, identifying modifiable risk factors during the preclinical window is one of the most important frontiers in public health. The projected cost of managing Alzheimer’s disease in the US alone is expected to exceed $600 billion annually by 2050, and the population aged 65 and over is expected to double in the same period.
Against that backdrop, a dietary intervention as accessible and affordable as moderate egg consumption associated with a 17% to 27% reduction in Alzheimer’s risk warrants serious attention. Not as a magic bullet, but as a component of a nutritionally complete diet that supports the aging brain.
The Takeaway
Across 15 years and nearly 40,000 participants, eating eggs even occasionally was consistently associated with a lower risk of Alzheimer’s disease. Eating none at all was associated with meaningfully higher risk. The biological mechanisms are plausible, the statistical evidence is rigorous, and the effect was maintained across every level of dietary and lifestyle adjustment.
Whether you have eggs once a week or most mornings, the evidence now suggests your brain may be quietly benefiting.
REFERENCES
Oh, J., Oda, K., Chiriac, G., Fraser, G. E., Sirirat, R., & Sabaté, J. (2026). Egg intake and the incidence of Alzheimer’s disease in the Adventist Health Study-2 cohort linked with Medicare data. The Journal of Nutrition. https://doi.org/10.1016/j.tjnut.2026.101541